Qlife Holding
0.011 SEK -5.22%HC Andersen Capital receives payment from Qlife Holding for a DigitalIR/Corporate Visibility agreement. See disclaimer.
Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarkers and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information is facilitated, which can contribute to better treatment and potentially prevent diseases. The first capsules in the company's product, Egoo.Health Platform, were CE-marked for professional use in early 2020. The company has patent protection for key parts of its technology. The Danish-based company is listed on Nasdaq First North Stockholm.
Read moreLatest research
Latest videos
Financial calendar
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Trådgårdshuset Nissarna AB | 7.8 % | 7.8 % |
Försäkringsbolaget Avanza Pension | 6.6 % | 6.6 % |
Premium
This content is for our Premium customers only.
Qlife Holding AB: UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU
Qlife Holding AB: Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships
Join Inderes community
Don't miss out - create an account and get all the possible benefits